Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
& Benson, C
Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blockerresults from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancer
Food Chemistry, 351 , Article 129289
Ethics declarations Conflict of interest F.C.S declares grants from NIH/NIDDK (P30 DK040561, U24 DK132733, and UE5 DK137285) and consulting fees from Eli Lilly, Novo Nordisk, Amgen, Boehringer Ingelheim, AstraZeneca, AbbVie, Currax, Pfizer, Doximity, MelliCell, Vida Health, Empros Pharma, Apnimed, Clearmind Medicine, and Ilant Health, all outside of the current work
US$ 29.22
US$ 27.79
US$ 27.75
US$ 29.88
US$ 20.95
US$ 22.63
US$ 29.77
US$ 21.45
